Adenosine A2A receptor agonist (CGS-21680) prevents endotoxin-induced effects on nucleotidase activities in mouse lymphocytes

European Journal of Pharmacology

Volumn 651, Issue 1-3, 2011, Pages 212-217

  Vuaden, Fernanda Cenci ^a   Savio, Luiz Eduardo Baggio ^a,b   Bastos, Carolina Maria Alves ^c   Bogo, Maurício Reis ^b   Bonan, Carla Denise ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

5 Nucleotidase; Adenosine; Lipopolysaccharide; Lymphocytes; Nucleoside triphosphate diphosphohydrolase; Nucleotide pyrophosphatase phosphodiesterase

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 NITROPHENYLTHYMIDINE PHOSPHATE; ADENOSINE A2A RECEPTOR; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ECTO 5' NUCLEOTIDASE; ECTO NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; ECTO NUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE; ENDOTOXIN; NUCLEOSIDE; NUCLEOTIDASE; NUCLEOTIDE; THYMIDINE PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CATABOLISM; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; GENE EXPRESSION; LYMPHOCYTE; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; TRANSCRIPTION REGULATION;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; ENDOTOXEMIA; ENDOTOXINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPOPOLYSACCHARIDES; LYMPH NODES; LYMPHOCYTES; MALE; MICE; NUCLEOTIDASES; PHENETHYLAMINES; RECEPTOR, ADENOSINE A2A; RNA, MESSENGER;

EID: 78650662869     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.11.003     Document Type: Article

References (44)

1. L. Airas CD73 and adhesion of B-cells to follicular dendritic cells Leuk. Lymphoma 29 1998 37 47
2. P. Bodin, and G. Burnstock Increased release of ATP from endothelial cells during acute inflammation Inflamm. Res. 47 1998 351 354
3. P.L. Capecchi, A. Camurri, G. Pompella, A. Mazzola, M. Maccherini, F. Diciolla, P.E. Lazzerini, M.P. Abbracchio, and F. Laghi-Pasini Upregulation of A2A adenosine receptor expression by TNF-α in PBMC of patients with CHF: a regulatory mechanism of inflammation J. Card. Fail. 11 2006 67 73
4. 2+-stimulated ATPase activity Anal. Biochem. 157 1986 375 380
5. R.M. Condie, S.J. Zak, and R.A. Good Effect of meningococcal endotoxin on the immune response Proc. Soc. Exp. Biol. Med. 90 1968 355 360
6. S. Deaglio, K.M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J.F. Chen, K. Enjyoji, J. Linden, M. Oukka, V.K. Kuchroo, T.B. Strom, and S.C. Robson Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression J. Exp. Med. 204 2007 1257 1265
7. F. Di Virgilio Purinergic signalling in the immune system. A brief update Purinergic Signal. 3 2007 1 3
8. F. Di Virgilio, S. Ceruti, P. Bramanti, and M.P. Abbracchio Purinergic signalling in inflammation of the central nervous system Trends Neurosci. 32 2009 79 87
9. K.E. Dombrowski, Y. Ke, L.F. Thompson, and J.A. Kapp Antigen recognition by CTL is dependent upon ectoATPase activity J. Immunol. 154 1995 6227 6237
10. K.E. Dombrowski, Y. Ke, K.A. Brewer, and J.A. Kapp Ecto-ATPase: an activation marker necessary for effector cell function Immunol. Rev. 161 1998 111 118
11. K.M. Dwyer, S. Deaglio, W. Gao, D. Friedman, T.B. Strom, and S.C. Robson CD39 and control of cellular immune responses Purinergic Signal. 3 2007 171 180
12. A.A. Erdmann, Z.G. Gao, U. Jung, J. Foley, T. Borenstein, K.A. Jacobson, and D.H. Fowler Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo Blood 105 2005 4707 4714
13. D. Ferrari, C. Pizzirani, E. Adinolfi, M.R. Lemoli, A. Curti, M. Idzko, E. Panther, and F. Di Virgilio The P2X7 receptor: a key player in IL-1 processing and release J. Immunol. 176 2006 3877 3883
14. B.B. Fredholm, A.P. Ijzerman, K.A. Jacobson, K.N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacol. Rev. 53 2001 527 552
15. T. Genovese, A. Melani, E. Esposito, E. Mazzon, R. Di Paola, P. Bramanti, F. Pedata, and S. Cuzzocrea The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cord Shock 32 6 2009 578 585
16. J.W. Goding, B. Grobben, and H. Slegers Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/ phosphodiesterase family Biochim. Biophys. Acta 1638 2003 1 19
17. G. Hasko, D.G. Kuhel, J.F. Chen, M.A. Schwarzschild, E.A. Deitch, J.G. Mabley, A. Marton, and C. Szabo Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor dependent and independent mechanisms FASEB J. 14 2000 2065 2074
18. G. Hasko, and B.N. Cronstein Adenosine: an endogenous regulator of innate immunity Trends Immunol. 25 2004 33 39
19. G. Hasko, and P. Pacher A2A receptors in inflammation and injury: lessons learned from transgenic animals J. Leukoc. Biol. 83 2008 447 455
20. S. Huang, S. Apasov, M. Koshiba, and M. Sitkovsky Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion Blood 90 1997 1600 1610
21. L.M. Kreckler, E. Gizewski, T.C. Wan, and J.A. Auchampach Adenosine suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production by murine macrophages through a protein kinase A- and exchange protein activated by cAMP-independent signaling pathway J. Pharmacol. Exp. Ther. 331 3 2009 1051 1061
22. M. Koshiba, D.L. Rosin, N. Hayashi, J. Linden, and M.V. Sitkovsky Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies Mol. Pharmacol. 55 1999 614 624
23. C.M. Lappas, J.M. Rieger, and J. Linden A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells J. Immunol. 174 2005 1073 1080
24. C.M. Lappas, Y.J. Day, M.A. Marshall, V.H. Engelhard, and J. Linden Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation J. Exp. Med. 203 2006 2639 2648
25. J. Linden Adenosine in tissue protection and tissue regeneration Mol. Pharmacol. 67 2005 1385 1387
26. A. Martire, G. Calamandrei, F. Felici, M.L. Scattoni, G. Lastoria, M.R. Domenici, M.T. Tebano, and P. Popoli Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice Neurosci. Lett. 471 2007 78 83
27. R. Medzhitov Origin and physiological roles of inflammation Nature 454 2008 428 435
28. N. Nedeljkovic, A. Banjac, A. Horvat, M. Stojiljkovic, and G. Nikezic Developmental profile of NTPDase activity in synaptic plasma membranes isolated from rat cerebral cortex Int. J. Dev. Neurosci. 23 2005 45 51
29. M. Odashima, G. Bamias, J. Rivera-Nieves, J. Linden, C.C. Nast, C.A. Moskaluk, M. Marini, K. Sugawara, K. Kozaiwa, M. Otaka, S. Watanabe, and F. Cominelli Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease Gastroenterology 129 2005 26 33
30. A. Ohta, and M. Sitkovsky Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage Nature 414 2001 916 920
31. A. Ohta, and M. Sitkovsky The adenosinergic immunomodulatory drugs Curr. Opin. Pharmacol. 9 2009 1 6
32. R. Pawlinski, B. Pedersen, B. Kehrle, W.C. Aird, R.D. Frank, M. Guha, and N. Mackman Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model Blood 101 2003 3940 3947
33. G. Pinhal-Enfield, M. Ramanathan, G. Hasko, S.N. Vogel, A.L. Salzman, G.J. Boons, and S.J. Leibovich An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors Am. J. Pathol. 163 2003 711 721
34. R. Resta, Y. Yamashita, and L.F. Thompson Ecto-enzyme and signaling functions of lymphocyte CD73 Immunol. Rev. 161 1998 95 109
35. H. Sakura, S. Nagashima, A. Nakahima, and M. Maeda Characterization of fetal serum 50-nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation Thromb. Res. 91 1998 83 89
36. C.P. Sevigny, L. Li, A.S. Awad, L. Huang, M. McDuffie, J. Linden, P.I. Lobo, and M.D. Okusa Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition J. Immunol. 178 2007 4240 4249
37. M.V. Sitkovsky Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo Biochem. Pharmacol. 65 2003 493 501
38. M.V. Sitkovsky, and A. Ohta The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol. 26 2005 299 304
39. 2A receptor agonists as anti-inflammatory agents Curr. Opin. Investig. Drugs 4 2003 1313 1319
40. G.W. Sullivan, G. Fang, J. Linden, and W.M. Scheld Adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis J. Infect. Dis. 189 2004 1897 1904
41. 2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases Microbes Infect. 5 2003 515 526
42. F.C. Vuaden, G.P. Cognato, C. Bonorino, M.R. Bogo, J.J.F. Sarkis, and C.D. Bonan Lipopolysaccharide alters nucleotidase activities from lymphocytes and serum of rats Life Sci. 80 2007 1784 1791
43. F.C. Vuaden, C.R. Fürstenau, L.E.B. Savio, J.J.F. Sarkis, and C.D. Bonan Endotoxemia alters nucleotide hydrolysis in platelets of rats Platelets 20 2009 83 89
44. H. Zimmermann Ectonucleotidases: some recent developments and note on nomenclature Drug Dev. Res. 52 2001 46 56